Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.21.2
Segment Information (Tables)
 9 Months Ended
Jun. 27, 2021
Segment Reporting [Abstract]  
Revenues, EBT, and Assets for reportable segments
The table below presents revenues and EBT for reportable segments (in millions):
Three Months Ended Nine Months Ended
June 27,
2021		 June 28,
2020		 June 27,
2021		 June 28,
2020
Revenues
QCT $ 6,472  $ 3,807  $ 19,287  $ 11,526 
QTL 1,489  1,044  4,762  3,520 
QSI 11  3  30  33 
Reconciling items 88  39  151  106 
Total $ 8,060  $ 4,893  $ 24,230  $ 15,185 
EBT
QCT $ 1,795  $ 603  $ 5,299  $ 1,748 
QTL 1,053  646  3,514  2,335 
QSI 156  153  412  (58)
Reconciling items (747) (534) (2,236) (1,612)
Total $ 2,257  $ 868  $ 6,989  $ 2,413 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended Nine Months Ended
June 27,
2021		 June 28,
2020		 June 27,
2021		 June 28,
2020
Revenues
Nonreportable segments $ 34  $ 39  $ 97  $ 106 
Unallocated revenues (Note 2) 54  —  54  — 
$ 88  $ 39  $ 151  $ 106 
EBT
Unallocated revenues (Note 2) $ 54  $ —  $ 54  $ — 
Unallocated cost of revenues (73) (87) (220) (262)
Unallocated research and development expenses (505) (271) (1,325) (746)
Unallocated selling, general and administrative expenses (125) (103) (418) (275)
Unallocated other income (Note 2) —  —  —  23 
Unallocated interest expense (138) (142) (420) (434)
Unallocated investment and other income, net 55  76  140  129 
Nonreportable segments (15) (7) (47) (47)
$ (747) $ (534) $ (2,236) $ (1,612)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended Nine Months Ended
June 27,
2021		 June 28,
2020		 June 27,
2021		 June 28,
2020
Revenues
Nonreportable segments $ 34  $ 39  $ 97  $ 106 
Unallocated revenues (Note 2) 54  —  54  — 
$ 88  $ 39  $ 151  $ 106 
EBT
Unallocated revenues (Note 2) $ 54  $ —  $ 54  $ — 
Unallocated cost of revenues (73) (87) (220) (262)
Unallocated research and development expenses (505) (271) (1,325) (746)
Unallocated selling, general and administrative expenses (125) (103) (418) (275)
Unallocated other income (Note 2) —  —  —  23 
Unallocated interest expense (138) (142) (420) (434)
Unallocated investment and other income, net 55  76  140  129 
Nonreportable segments (15) (7) (47) (47)
$ (747) $ (534) $ (2,236) $ (1,612)